PulmOne

What PulmOne does

PulmOne Advanced Medical Devices Ltd. is an Israeli-founded (2006, Ra'ananna) private medical device company that has developed and commercialized the MiniBox+, a portable, cabinless, and gasless pulmonary function testing (PFT) device. The product combines spirometry, lung volume measurements via the proprietary Partial Volume Method (PVM) with a 15.8 L reference volume, and single-breath diffusing capacity (DLCO) testing using an infrared high-speed gas analyzer, all within an 18-pound desktop unit suitable for any exam room. PulmOne's primary customers are office-based pulmonologists and allergists/immunologists who need complete PFT capability without the dedicated space, gas cylinders, and specialized technicians required by traditional body plethysmography. Secondary customers include hospital pulmonary labs, cardiology practices, pediatric pulmonary specialists, and multi-site pulmonary networks.

The business model is anchored on capital equipment sales of the MiniBox+ device (pricing undisclosed, quote-based), supplemented by recurring consumables (single-use 0.025-micron bacterial/viral filters), an included MiniBox+ Customer Care service program (factory warranty, virtual training, remote support, loaner devices), and optional add-ons including the NIOX VERO FeNO system (via partnership with NIOX/Circassia) and the MiniBox+ Cart workstation accessory. PulmOne distributes through direct field sales organizations in the US (Dallas-Fort Worth HQ), France (Nimes), UKI (London), Japan (Tokyo), and Brazil (Sao Paulo), plus the HTDK distributor in China.

The company has secured FDA 510(k) clearance (October 2016) plus Health Canada, TGA Australia, Japanese BSI, and Korean MFDS approvals, with Brazil and China launches following in 2023. Clinical evidence includes a CHEST 2021 multi-center study of 266 participants validating equivalence to body plethysmography, an Italian multi-center Clinicoecon Outcomes Res 2021 study, and over 700 patients tested across 11 medical centers in the US and Europe. The Scientific Advisory Board includes Harvard and Cincinnati Children's Hospital faculty. Revenue figures are not publicly disclosed, and disclosed funding is minimal (~$525K cumulative via OurCrowd), suggesting the company has grown primarily through operational cash flow rather than large external capital raises.

Name

PulmOne

Legal name

PulmOne Advanced Medical Devices Ltd.

Website

https://pulm-one.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

PulmOne is an Israeli-founded medical device company that manufactures the MiniBox+, a portable, cabinless, and gasless pulmonary function testing device. It targets office-based pulmonologists, allergists, and immunologists needing complete PFT (spirometry, lung volumes, DLCO) without a traditional body box.

Ownership category

akta.pro rank

Product category

Pulmonary Function Testing Equipment

NAICS

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Pulmonary Function Testing (PFT) & Spirometry Equipment (HLAHAGAH)

akta.pro secondary industry

Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD)

Keywords

• Portable pulmonary function testing
• Cabinless plethysmograph device
• Lung volume measurement equipment
• Spirometry and DLCO testing
• Respiratory diagnostics hardware

Headquarters

HQ city

Ra'ananna

HQ country

Israel

HQ region

Middle East

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Marketing or Sales, Technology or R&D, Operations, Supply Chain

Revenue model

1. MiniBox+ Device Sales: One-time capital equipment sale of the MiniBox+ portable PFT device. Sold directly to hospitals, pulmonary clinics, and private practices through field sales teams and regional distributors. The device is also available with an optional cart for workstation mobility. Purchase model is complemented by a customer portal with a shop for accessories and consumables.
2. MiniBox+ Customer Care Program (Service & Support): Comprehensive support program including full factory warranty for hardware and software, virtual training, online refresher videos, remote technical support, free software upgrades, and free loaner devices during servicing.
3. Consumables (Filters, DLco Gas): Single-use 0.025 micron bacterial/viral filters required per patient. DLco gas is purchased through an independent medical gas distributor; customer service facilitates the procurement process.
4. NIOX VERO Integration (FeNO): Optional add-on of the NIOX VERO fractional exhaled nitric oxide (FeNO) airway inflammation measurement system offered alongside the MiniBox+ to both existing customers and new buyers, expanding the diagnostic offering.

Pricing tiers

Go-to-market motion2 records

Distribution channels7 records

Marketing channels8 records

Core offering

PulmOne develops, manufactures, and sells the MiniBox+, a portable, cabinless, gasless pulmonary function testing (PFT) device that combines spirometry, lung volume measurements (via proprietary Partial Volume Method), and single-breath DLCO in a single compact desktop unit. The device is sold to pulmonologists, allergists, immunologists, hospitals, and private practices as a capital equipment replacement for traditional body plethysmography. Ancillary offerings include a MiniBox+ Cart accessory, NIOX VERO FeNO add-on, consumables (filters, DLCO gas), and a bundled Customer Care support program.

Product overview

PulmOne offers the MiniBox+ as its flagship core product — a compact, portable plethysmograph that combines spirometry, lung volume measurements, and diffusing capacity (DLCO) testing in a single desktop device. The product portfolio includes the MiniBox+ as the primary offering, with an optional MiniBox+ Cart for mobile workstation capability, and the NIOX VERO FeNO system as an add-on for expanded respiratory diagnostics. The MiniBox+ is designed as a cabinless, gasless alternative to traditional body box systems, enabling complete pulmonary function testing in any clinical setting without requiring dedicated lab space.

Differentiator

Problem solved

Functional benefit

Products and services

• MiniBox+ A portable, cabinless pulmonary function test (PFT) machine for rapid, easy testing of Spirometry, Lung Volumes, and Single-Breath DLCO. Features fully automatic measurements, compact desktop design, and no requirement for gas cylinders or dedicated lab space. Suitable for pulmonologists, allergists, and immunologists in outpatient settings. Includes integrated DLCO module with CO2 and ketone compensation, self-calibrating sensors, ATS/ERS guideline compliance, and pediatric use from age 5.
• MiniBox+ Cart An optional dedicated cart providing a workstation on wheels for the MiniBox+, including compartments for a gas cylinder, printer, and spare filters. Enables complete mobility of the pulmonary function testing system between exam rooms or facilities.
• NIOX VERO (FeNO) Add-on Fractional exhaled nitric oxide (FeNO) airway inflammation measurement system offered as an add-on to the MiniBox+ for combined respiratory diagnostics. Offered in partnership with NIOX (Circassia) to both existing PulmOne customers and new buyers, expanding diagnostic capabilities for asthma management.
• MiniBox+ Customer Care Program A comprehensive support program bundled with MiniBox+ purchase that includes full factory warranty for hardware and software, virtual training, online refresher videos, remote technical support, free software upgrades, and free loaner devices during servicing. Provides post-sale support and customer success services for MiniBox+ owners.
• MiniBox+ Consumables (Filters and DLCO Gas) Single-use 0.025 micron bacterial/viral filters required per patient (99.999% cross-infection protection) and DLCO gas (purchased through an independent medical gas distributor with PulmOne customer service facilitating procurement). Sold as recurring consumables through the customer portal shop.

Quantifiable outcome

• MiniBox+ lung volumes are equivalent to body plethysmography (body box) as shown in a CHEST 2021 multi-center study with 266 participants across multiple medical centers.
• +5 more outcomes

Named customers14 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• HTDK (China Distributor)coreChannel Partner/ Reseller/ Distributor · 20 September 2023HTDK is PulmOne's exclusive distributor for the MiniBox+ in China. HTDK exhibited at the 2023 Annual Congress of the Chinese Thoracic Society (CTS) to introduce the MiniBox+ to Chinese pulmonologists.
• NIOX (Circassia)coreTechnology or Integration · 7 November 2019PulmOne offers the NIOX VERO fractional exhaled nitric oxide (FeNO) airway inflammation measurement system as an add-on to the MiniBox+. The combined system is offered to both companies' existing customers and new buyers, expanding the diagnostic capabilities of the MiniBox+ platform to include FeNO testing for asthma management.

Scale indicators5 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Medisoft: Belgium-based manufacturer of pulmonary function testing equipment (spirometry, body plethysmography, DLCO). Direct competitor to PulmOne in European pulmonology practices with overlapping in-office PFT solutions.
• Vyaire Medical: One of the largest global manufacturers of pulmonary function testing and respiratory diagnostics equipment, including body plethysmography and spirometry systems used in hospitals and pulmonary labs. Directly competes with PulmOne in the same PFT category and serves overlapping pulmonology and allergy customers.
• COSMED: Italy-headquartered manufacturer of cardiopulmonary diagnostic equipment including PFT systems, metabolic carts, and spirometers. Competes with PulmOne for pulmonology and primary-care PFT customers globally, with overlapping product offerings.
• MGC Diagnostics: US-based manufacturer of cardiorespiratory diagnostic systems including body plethysmographs, spirometers, and DLCO systems. Competes head-to-head with PulmOne for in-office and lab PFT customers across pulmonology practices and hospitals.
• nSpire Health: Manufacturer of pulmonary function testing and respiratory diagnostics equipment (spirometry, lung volumes, esophageal manometry). Direct competitor to PulmOne in the PFT device category, with a long-standing presence in pulmonology practices.
• Morgan Scientific: US-based manufacturer of pulmonary function testing and respiratory diagnostics equipment (spirometry, lung volumes, DLCO). Direct competitor to PulmOne for in-office and lab-based PFT customers in the US pulmonology market.

Broad incumbents

• Nihon Kohden: Japan-based global medical device company with a respiratory diagnostics portfolio that includes spirometry and PFT systems. Competes with PulmOne in the Japanese and broader Asian PFT market, but as part of a much broader patient-monitoring and diagnostics portfolio.
• BD (formerly CareFusion / Viasys): BD's respiratory diagnostics franchise (legacy Viasys/CareFusion) supplies PFT systems, body plethysmography, and consumables to hospitals worldwide. Competes with PulmOne in hospital and large pulmonary labs as part of BD's broader medical product portfolio.
• Schiller AG: Swiss manufacturer of cardiopulmonary diagnostics including spirometry, PFT, and ECG. Overlaps with PulmOne in office-based lung function testing, but operates as a broad incumbent across cardiology and pulmonary diagnostics rather than a PFT pure-play.

Emerging players

• Circassia (NIOX): UK-based respiratory diagnostics company focused on fractional exhaled nitric oxide (FeNO) measurement for asthma management. PulmOne's NIOX VERO integration partner; serves overlapping allergist and pulmonology customers for asthma workups, though with a focused, single-modality offering rather than full PFT.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pulmone-advanced-medical-devices-ltd

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Subsidiaries4 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PulmOne